Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Adalimumab (Humira TM) is approved by both the FDA and the EMA for the treatment of Crohn's Disease (CD). The approval includes the treatment of adult and pediatric patients aged 6 years and older with moderate to severe Crohn's Disease when previous therapies have not been sufficiently effective. The medication is registered as a monoclonal antibody against TNF-alfa in the USA and the EU for this indication. Biosimilars like Amgevita are also available for this indication.
…